MRI-guided Radiation Therapy (MRgRT), FLASH proton therapy, concurrent immunotherapy, and radiation therapy and SBRT for oligometastatic disease, are emerging technologies and approaches to optimize cancer care.

SBRT for oligometastatic disease of mixed histologies has been shown to improve progression-free and even overall survival. A large cooperative group study recently demonstrated that there was no overall survival advantage seen when constrained to breast cancer alone.

HyTEC (Hypo-fractionated or “Hy”-dose per fraction, Treatment Effects in the Clinic) was an American Association of Physicists in Medicine-led initiative focusing on hypofractionated SBRT/SABR and stereotactic radiosurgery in adults.

The field of cancer is a rapidly evolving field with new treatment approaches moving to clinic on a daily basis. Radiation Oncology is no different. It is extremely difficult for a practicing clinician to stay abreast of new developments in cancer care.

The associated article is a meta-analysis reviewing published studies for SBRT for HCC with 5+ years of outcome data. 19 studies were identified that met the criteria. The article reviews those 19 studies and makes recommendations for appropriate SBRT for HCC.

Recent publications have established SBRT as the standard of care in painful spine metastases. As a result, spine SBRT is being increasingly utilized in both academic and community practices, rendering this educational activity timely.

This activity reviews the various oligometastatic states, existing and upcoming data supporting radiation in appropriately selected patients, intersection of radiation with systemic therapy, and practical applications of radiation treatment delivery with a focus on stereotactic ablative radiation

This activity provides an opportunity to understand the key steps in the process of care for SBRT treatment of liver (primary and metastases), focusing on patient selection, imaging, simulation, treatment planning and image guidance, and discuss challenges in motion management and delivery.

This activity focuses on difficult cases in the use of lung SBRT. It includes a set of challenging cases followed by a short didactic session on each challenging topic. The cases/topics include: 1) SBRT for a large (>5 cm) primary, node negative tumor.